STOCK TITAN
  1. Home
  2. SEC Filings
  3. TRAXV

First Tracks Biotherapeutics (TRAXV) SEC Filings, Apr 1, 2026

TRAXV NASDAQ
Form 3

Director Rita Jain joins First Tracks Biotherapeutics (TRAXV) as reporting insider

Rhea-AI Summary

First Tracks Biotherapeutics, Inc. director Rita Jain filed an initial Form 3, formally registering as an insider of the company. The filing reports no transactions, no derivative activity, and no specific share holdings at this time.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many First Tracks Biotherapeutics (TRAXV) SEC filings are available on StockTitan?

StockTitan tracks 31 SEC filings for First Tracks Biotherapeutics (TRAXV). Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for First Tracks Biotherapeutics (TRAXV)?

The most recent SEC filing for First Tracks Biotherapeutics (TRAXV) was filed on April 1, 2026.